FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311663807> ?p ?o ?g. }

• W4311663807 endingPage "51" @default.
• W4311663807 startingPage "45" @default.
• W4311663807 abstract "Burkitt's lymphoma (BL) has a particularly extremely poor prognosis and the fastest growth rate among human tumors, and the development of new drugs for the treatment of BL is urgently needed. In this study, the cytotoxic properties of 3,7-bis(3,5-dimethylphenyl)-aaptamine (AP-51), a new semisynthetic alkaloid derived from the marine natural product aapatamine, were investigated using BL cell lines. Our results showed that AP-51 inhibited the proliferation of Daudi and Raji cells with IC50 values of 3.48 and 2.07 μM, respectively. Flow cytometry and Western blot analyses showed that AP-51 initiated G0/G1 phase arrest by modulating the expression of cyclin-dependent kinases (CDKs). AP-51 also induced apoptosis, as demonstrated by nuclear fragmentation, downregulation of BCL-XL and Mcl-1, and upregulation of cleaved caspase-9, cleaved caspase-3, cleaved-PARP, and cytochrome c, the markers of apoptosis regulated via the mitochondrial pathway. When it comes to mitochondria, AP-51 treatment also significantly increased the levels of intracellular mitochondrial superoxide, decreased ATP content, and reduced the expression of ATP synthase, as well as the expression of the mitochondrial respiratory chain complexes. Finally, AP-51 treatment significantly inhibited the PI3K/AKT/mTOR signaling pathway, which was shown to be associated with the induction of apoptosis. Collectively, these findings indicated that AP-51 initiated cell cycle arrest, induced apoptosis, caused mitochondrial dysfunction, and decreased the phosphorylation of PI3K/AKT/mTOR signaling pathway-related proteins and the protein levels of C-MYC, suggesting that AP-51 has therapeutic potential as a possible treatment for Burkitt's lymphoma." @default.
• W4311663807 created "2022-12-27" @default.
• W4311663807 creator A5000395994 @default.
• W4311663807 creator A5011320222 @default.
• W4311663807 creator A5014465828 @default.
• W4311663807 creator A5029172602 @default.
• W4311663807 creator A5033741211 @default.
• W4311663807 creator A5049136138 @default.
• W4311663807 creator A5081264867 @default.
• W4311663807 date "2022-12-16" @default.
• W4311663807 modified "2023-10-16" @default.
• W4311663807 title "Marine Sponge-Derived Alkaloid Induces Mitochondrial Dysfunction and Inhibits the PI3K/AKT/mTOR Signaling Pathway against Burkitt’s Lymphoma" @default.
• W4311663807 cites W1020989877 @default.
• W4311663807 cites W1537016208 @default.
• W4311663807 cites W1919120370 @default.
• W4311663807 cites W1972078736 @default.
• W4311663807 cites W1975280591 @default.
• W4311663807 cites W1978279201 @default.
• W4311663807 cites W1988339935 @default.
• W4311663807 cites W1988728679 @default.
• W4311663807 cites W2023971274 @default.
• W4311663807 cites W2025565782 @default.
• W4311663807 cites W2029829614 @default.
• W4311663807 cites W2035818879 @default.
• W4311663807 cites W2043843485 @default.
• W4311663807 cites W2054933011 @default.
• W4311663807 cites W2059712789 @default.
• W4311663807 cites W2144002645 @default.
• W4311663807 cites W2148133242 @default.
• W4311663807 cites W2339156133 @default.
• W4311663807 cites W2574903829 @default.
• W4311663807 cites W2614314029 @default.
• W4311663807 cites W2625477833 @default.
• W4311663807 cites W2773985729 @default.
• W4311663807 cites W2803381277 @default.
• W4311663807 cites W2803702013 @default.
• W4311663807 cites W2808123627 @default.
• W4311663807 cites W2884174891 @default.
• W4311663807 cites W2886386069 @default.
• W4311663807 cites W2940861038 @default.
• W4311663807 cites W2955019775 @default.
• W4311663807 cites W2969876208 @default.
• W4311663807 cites W3012638502 @default.
• W4311663807 cites W3092258572 @default.
• W4311663807 cites W3104559933 @default.
• W4311663807 cites W358640895 @default.
• W4311663807 doi "https://doi.org/10.1021/acs.jnatprod.2c00673" @default.
• W4311663807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36524671" @default.
• W4311663807 hasPublicationYear "2022" @default.
• W4311663807 type Work @default.
• W4311663807 citedByCount "0" @default.
• W4311663807 crossrefType "journal-article" @default.
• W4311663807 hasAuthorship W4311663807A5000395994 @default.
• W4311663807 hasAuthorship W4311663807A5011320222 @default.
• W4311663807 hasAuthorship W4311663807A5014465828 @default.
• W4311663807 hasAuthorship W4311663807A5029172602 @default.
• W4311663807 hasAuthorship W4311663807A5033741211 @default.
• W4311663807 hasAuthorship W4311663807A5049136138 @default.
• W4311663807 hasAuthorship W4311663807A5081264867 @default.
• W4311663807 hasConcept C104317684 @default.
• W4311663807 hasConcept C124320809 @default.
• W4311663807 hasConcept C12519072 @default.
• W4311663807 hasConcept C127561419 @default.
• W4311663807 hasConcept C153911025 @default.
• W4311663807 hasConcept C185592680 @default.
• W4311663807 hasConcept C190283241 @default.
• W4311663807 hasConcept C29311851 @default.
• W4311663807 hasConcept C29537977 @default.
• W4311663807 hasConcept C31573885 @default.
• W4311663807 hasConcept C55493867 @default.
• W4311663807 hasConcept C75217442 @default.
• W4311663807 hasConcept C86554907 @default.
• W4311663807 hasConcept C86803240 @default.
• W4311663807 hasConcept C95444343 @default.
• W4311663807 hasConceptScore W4311663807C104317684 @default.
• W4311663807 hasConceptScore W4311663807C124320809 @default.
• W4311663807 hasConceptScore W4311663807C12519072 @default.
• W4311663807 hasConceptScore W4311663807C127561419 @default.
• W4311663807 hasConceptScore W4311663807C153911025 @default.
• W4311663807 hasConceptScore W4311663807C185592680 @default.
• W4311663807 hasConceptScore W4311663807C190283241 @default.
• W4311663807 hasConceptScore W4311663807C29311851 @default.
• W4311663807 hasConceptScore W4311663807C29537977 @default.
• W4311663807 hasConceptScore W4311663807C31573885 @default.
• W4311663807 hasConceptScore W4311663807C55493867 @default.
• W4311663807 hasConceptScore W4311663807C75217442 @default.
• W4311663807 hasConceptScore W4311663807C86554907 @default.
• W4311663807 hasConceptScore W4311663807C86803240 @default.
• W4311663807 hasConceptScore W4311663807C95444343 @default.
• W4311663807 hasFunder F4320321001 @default.
• W4311663807 hasFunder F4320321540 @default.
• W4311663807 hasFunder F4320322999 @default.
• W4311663807 hasIssue "1" @default.
• W4311663807 hasLocation W43116638071 @default.
• W4311663807 hasLocation W43116638072 @default.
• W4311663807 hasOpenAccess W4311663807 @default.
• W4311663807 hasPrimaryLocation W43116638071 @default.
• W4311663807 hasRelatedWork W2029953588 @default.

• next